Related Experiment Video
Updated: Sep 5, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19.
Maximilian Peter Götz1, Mikkel-Ole Skjoedt2,3, Rafael Bayarri-Olmos2
1Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark, maximilianpetergoetz@gmail.com.
Mannose-binding lectin-associated serine protease 2 (MASP-2) levels increase in active COVID-19 patients, correlating with complement activation and inflammation. This suggests MASP-2 plays a role in COVID-19 pathophysiology, aiding in disease understanding.
Area of Science:
- Immunology
- Complement System
- Virology
Background:
- Mannose-binding lectin-associated serine protease 2 (MASP-2) activates the lectin complement pathway.
- MASP-2 involvement in COVID-19 pathophysiology is hypothesized.
- A sensitive and reliable assay for MASP-2 is needed.
Purpose of the Study:
- To develop a specific and quantitative MASP-2 enzyme-linked immunosorbent assay (ELISA).
- To investigate MASP-2 concentrations in healthy controls and COVID-19 patients.
- To explore the correlation between MASP-2 and complement activation/inflammatory markers in COVID-19.
Main Methods:
- Development of a sandwich ELISA using novel mouse monoclonal antibodies against MASP-2.
- Assay validation for specificity, limit of quantification (0.1 ng/mL), and stability.
- Measurement of MASP-2 concentrations in plasma from 216 healthy controls, 347 convalescent COVID-19 patients, and 147 prospectively followed COVID-19 patients.
Main Results:
- The developed ELISA specifically detected MASP-2 and not its splice variant MAP-2.
- MASP-2 concentrations were stable after freeze-thaw cycles.
- Healthy controls had a mean MASP-2 of 524 ng/mL.
- No significant difference in MASP-2 was found in convalescent COVID-19 patients compared to controls.
- Prospectively followed COVID-19 patients showed a significant increase in MASP-2 (mean 834 ng/mL, p < 0.0001).
- In active COVID-19 patients, MASP-2 correlated with terminal complement complex, ficolins (ficolin-2, ficolin-3), and C-reactive protein.
Conclusions:
- A specific and quantitative MASP-2 ELISA was successfully developed.
- Elevated MASP-2 levels in active COVID-19 patients correlate with complement activation and inflammation.
- These findings support a potential role for MASP-2 in the pathophysiology of COVID-19.
More Related Videos
Related Concept Videos
Complement System
The Extrinsic Apoptotic Pathway
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
MAPK Signaling Cascades
Selectins

